AustLII Home | Databases | WorldLII | Search | Feedback

Australian Senate Standing Committee for the Scrutiny of Delegated Legislation - Monitor
You are here:  AustLII >> Databases >> Australian Senate Standing Committee for the Scrutiny of Delegated Legislation - Monitor >> 2009 >> [2009] AUSStaCSDLM 77

Database Search | Name Search | Recent Documents | Noteup | LawCite | Download | Help

Department of Health and Ageing [2009] AUSStaCSDLM 77 (14 May 2009)

DEPARTMENT OF HEALTH AND AGEING

Aged Care (Residential Care Subsidy — Amount of Accommodation Supplement) Determination 2009 (No. 1) under s. 44-5A(3) of the Aged Care Act 1997

[F2009L01156]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the method for determining the amount of the accommodation supplement.

Aged Care (Residential Care Subsidy — Amount of concessional Resident Supplement) Determination 2009 (No. 1) under s. 44-6(4) of the Aged Care Act 1997

[F2009L01160]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of the concessional resident supplement.

Aged Care (Residential Care Subsidy — Amount of Pensioner Supplement) Determination 2009 (No. 1) under s. 44-28(7) of the Aged Care Act 1997

[F2009L01151]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of the pensioner supplement.

Aged Care (Residential Care Subsidy — Amount of Respite Supplement) Determination 2009 (No. 1) under s. 44-12(3) of the Aged Care Act 1997

[F2009L01165]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of the respite supplement.

Aged Care (Residential Care Subsidy — Amount of Transitional Accommodation Supplement) Determination 2009 (No. 1) under s. 44-16(3) of the Aged Care Act 1997

[F2009L01166]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of the transitional accommodation supplement.

Aged Care (Residential Care Subsidy — Amount of Transitional Supplement) Determination 2009 (No. 1) under s. 44-16(3) of the Aged Care Act 1997

[F2009L01150]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of the transitional supplement.

Determination No. HIB 02/2009 under s. 3(1) of the Health Insurance Act 1973

[F2009L01144]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of patient contribution in respect of recognised hospitals in New South Wales.

Determination No. HIB 03/2009 under s. 3(1) of the Health Insurance Act 1973

[F2009L01145]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of patient contribution in respect of recognised hospitals in Queensland.

Determination No. HIB 04/2009 under s. 3(1) of the Health Insurance Act 1973

[F2009L01146]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of patient contribution in respect of recognised hospitals in South Australia.

Determination No. HIB 05/2009 under s. 3(1) of the Health Insurance Act 1973

[F2009L01147]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of patient contribution in respect of recognised hospitals in Tasmania.

Determination No. HIB 06/2009 under s. 3(1) of the Health Insurance Act 1973

[F2009L01148]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies the amount of patient contribution in respect of recognised hospitals in Victoria.

Gene Technology Amendment Regulations 2009 (No. 1)

Select Legislative Instrument 2009 No. 68
[F2009L01112]
Made
30/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Provide that inspectors from the Gene Technology Regulatory Scheme may perform functions under the Security Sensitive Biological Agents Regulatory Scheme.

Health Insurance (Diagnostic Imaging Services Table) Amendment Regulations 2009 (No. 1)

Select Legislative Instrument 2009 No. 60
[F2009L00840]
Made
9/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Enable Medicare benefits to be paid for magnetic resonance imaging services performed at specified locations.

Health Insurance (General Medical Services Table) Amendment Regulations 2009 (No. 1)

Select Legislative Instrument 2009 No. 61
[F2009L00112]
Made
9/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amend the descriptors of certain items in the Table.

Health Insurance (Gippsland and South Eastern New South Wales Mobile MRI Trial) Determination 2009 (No. 2) under s. 3C(1) of the Health Insurance Act 1973

[F2009L01614]
Made
28/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Provides for the payment of Medicare benefits for certain mobile MRI services.

Health Insurance (Pathology Services Table) Amendment Regulations 2009 (No. 1)

Select Legislative Instrument 2009 No. 62
[F2009L00829]
Made
9/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amend the table of pathology services in the principal Regulations.

Instrument No. PB 21 of 2009 under ss. 85, 85A and 88 of the National Health Act 1953

[F2009L01072]
Made
3/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies revisions to the list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Instrument No. PB 22 of 2009 under s. 84AF of the National Health Act 1953

[F2009L01073]
Made
3/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Determines, for specified brands of pharmaceutical items, the responsible persons for those brands.

Instrument No. PB 23 of 2009 under s. 85B of the National Health Act 1953

[F2009L01120]
Made
3/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amends the principal Determination concerning price determinations for pharmaceutical items.

Instrument No. PB 27 of 2009 under ss. 85A(1), 85A(2) and 88(1C) of the National Health Act 1953

[F2009L01118]
Made
3/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amends the principal Determination concerning the prescription of pharmaceutical benefits by authorised optometrists.

Instrument No. PB 28 of 2009 under ss. 85AB(1) and 85AC(1) of the National Health Act 1953

[F2009L01119]
Made
3/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies drugs that are assigned to the F1 and F2 formularies.

Instrument No. PB 29 of 2009 under s. 100(2) of the National Health Act 1953

[F2009L01221]
Made
31/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amends the arrangements for the availability of drugs and medicinal preparations under the Botulinum Toxin Program.

Instrument No. PB 30 of 2009 under subsection 84AAA(2) of the National Health Act 1953

[F2009L01354]
Made
14/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies an amended list of pharmaceutical items for the purposes of provisions in the Act dealing with early supply of pharmaceutical benefits.

Instrument No. PB 31 of 2009 under ss. 85(2), 85(2A) and 85(2AA) of the National Health Act 1953

[F2009L01248]
Made
2/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies revisions to the list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Instrument No. PB 32 of 2009 under ss. 85, 85A and 88 of the National Health Act 1953

[F2009L01249]
Made
2/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies revisions to the list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Instrument No. PB 33 of 2009 under s. 84AF of the National Health Act 1953

[F2009L01250]
Made
2/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Determines, for specified brands of pharmaceutical items, the responsible persons for those brands.

Instrument No. PB 34 of 2009 under s. 85B of the National Health Act 1953

[F2009L01251]
Made
2/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amends the principal Determination concerning price determinations for pharmaceutical items.

Instrument No. PB 35 of 2009 under s. 100(1) of the National Health Act 1953

[F2009L01254]
Made
2/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amends the arrangements for the availability of drugs and medicinal preparations under the Highly Specialised Drugs Program.

Instrument No. PB 36 of 2009 under s. 100(1) of the National Health Act 1953

[F2009L01255]
Made
2/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amends the arrangements for the availability of special pharmaceutical products under the chemotherapy pharmaceuticals access program.

Instrument No. PB 37 of 2009 under subsection 85AB(1) of the National Health Act 1953

[F2009L01445]
Made
2/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies drugs that are assigned to the F1 formulary.

Instrument No. PB 38 of 2009 under paragraph 98C(1)(b) of the National Health Act 1953

[F2009L01321]
Made
2/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Specifies conditions under which payments will be made in respect of the supply of pharmaceutical benefits by approved pharmacisits and approved medical practitioners.

Instrument No. PB 39 of 2009 under subsections 85(2), 85(2AA) and 85(2A) of the National Health Act 1953

[F2009L01713]
Made
1/05/2009
Tabled
13/05/2009 S
13/05/2009 HR
Summary
Specifies revisions to the list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Instrument No. PB 40 of 2009 under sections 85, 85A and 88 of the National Health Act 1953

[F2009L01712]
Made
1/05/2009
Tabled
14/05/2009 S
14/05/2009 HR
Summary
Specifies revisions to the list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Instrument No. PB 41 of 2009 under section 84AF of the National Health Act 1953

[F2009L01711]
Made
1/05/2009
Tabled
13/05/2009 S
13/05/2009 HR
Summary
Determines, for specified brands of pharmaceutical items, the responsible persons for those brands.

Instrument No. PB 42 of 2009 under paragraph 98C(1)(b) of the National Health Act 1953

[F2009L01714]
Made
1/05/2009
Tabled
13/05/2009 S
13/05/2009 HR
Summary
Specifies conditions under which payments will be made in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners.

Instrument No. PB 43 of 2009 under subsection 100(1) of the National Health Act 1953

[F2009L01716]
Made
1/05/2009
Tabled
14/05/2009 S
14/05/2009 HR
Summary
Amends the arrangements for the availability of drugs and medicinal preparations under the Highly Specialised Drugs Program.

Instrument No. PB 44 of 2009 under subsection 100(1) of the National Health Act 1953

[F2009L01715]
Made
1/05/2009
Tabled
14/05/2009 S
14/05/2009 HR
Summary
Amends the arrangements for the availability of special pharmaceutical products under the chemotherapy pharmaceuticals access program.

Order under subsection 3(1) — Definition of British Pharmacopoeia under subsection 3(1) of the Therapeutic Goods Act 1989

[F2009L01699]
Made
4/05/2009
Tabled
13/05/2009 S
13/05/2009 HR
Summary
Specifies a new edition of the British Pharmacopoeia for the purposes of the Act.

Private Health Insurance (Benefit Requirements) Amendment Rules 2009 (No. 2) under s. 333-20 of the Private Health Insurance Act 2007

[F2009L01140]
Made
18/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amend Schedule 3 of the principal Rules to reflect changes in Medical Benefits Schedule items.

Private Health Insurance (Benefit Requirements) Amendment Rules 2009 (No. 3) under item 3A of the table in section 333-20 of the Private Health Insurance Act 2007

[F2009L01717]
Made
30/04/2009
Tabled
13/05/2009 S
13/05/2009 HR
Summary
Specify two facilities which are eligible for second tier default benefits.

Private Health Insurance (Complying Product) Amendment Rules 2009 (No. 2) under s. 333-20 of the Private Health Insurance Act 2007

[F2009L01141]
Made
18/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Make minor amendments to a provision in the principal Rules concerning nursing-home type patient contribution at public hospitals.

Therapeutic Goods Amendment Regulations 2009 (No. 1)

Select Legislative Instrument 2009 No. 63
[F2009L00839]
Made
9/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amend the principal Regulations to permit members of the Medical Devices Evaluation Committee to be appointed for more than three consecutive terms, and amend the name of another body.

Therapeutic Goods (Listing) Notice 2009 (No. 1) under s. 9A(5) of the Therapeutic Goods Act 1989

[F2009L01384]
Made
15/04/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Permits the use of alpha-casozephone enriched hydrolysed milk protein as an active ingredient in listed medicines.

User Rights Amendment Principles 2009 (No. 1) under s. 96-1(1) of the Aged Care Act 1997

[F2009L01152]
Made
17/03/2009
Tabled
12/05/2009 S
12/05/2009 HR
Summary
Amend the provisions in the principal Principles concerning maximum daily accommodation charge for care recipients.

AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback
URL: http://www.austlii.edu.au/au/other/cth/AUSStaCSDLM/2009/77.html